LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Modrau, Boris"
  2. AU="Sallese, Anthony"
  3. AU="T Kennedy, Patrick"
  4. AU="Cheng, XiaoQing"
  5. AU="Onwuteaka-Philipsen, Bregje D"
  6. AU="Robert D. Welch"
  7. AU="Forget, Francois"

Suchergebnis

Treffer 1 - 10 von insgesamt 23

Suchoptionen

  1. Artikel ; Online: Effect of Remote Ischemic Conditioning in Ischemic Stroke Subtypes: A Post Hoc Subgroup Analysis From the RESIST Trial.

    Blauenfeldt, Rolf Ankerlund / Mortensen, Janne Kaergaard / Hjort, Niels / Valentin, Jan Brink / Homburg, Anne-Mette / Modrau, Boris / Sandal, Birgitte Forsom / Gude, Martin Faurholdt / Berhndtz, Anne Brink / Johnsen, Søren Paaske / Hess, David C / Simonsen, Claus Ziegler / Andersen, Grethe

    Stroke

    2024  Band 55, Heft 4, Seite(n) 874–879

    Abstract: Background: Remote ischemic conditioning (RIC) is a simple and noninvasive procedure that has proved to be safe and feasible in numerous smaller clinical trials. Mixed results have been found in recent large randomized controlled trials. This is a post ... ...

    Abstract Background: Remote ischemic conditioning (RIC) is a simple and noninvasive procedure that has proved to be safe and feasible in numerous smaller clinical trials. Mixed results have been found in recent large randomized controlled trials. This is a post hoc subgroup analysis of the RESIST trial (Remote Ischemic Conditioning in Patients With Acute Stroke), investigating the effect of RIC in different acute ischemic stroke etiologies, and whether an effect was modified by treatment adherence.
    Methods: Eligible patients were adults (aged ≥18 years), independent in activities of daily living, who had prehospital stroke symptoms with a duration of less than 4 hours. They were randomized to RIC or sham. The RIC treatment protocol consisted of 5 cycles with 5 minutes of cuff inflation alternating with 5 minutes with a deflated cuff. Acceptable treatment adherence was defined as when at least 80% of planned RIC cycles were received. The analysis was performed using the entire range (shift analysis) of the modified Rankin Scale (ordinal logistic regression).
    Results: A total of 698 had acute ischemic stroke, 253 (36%) were women, and the median (interquartile range) age was 73 (63-80) years. Median (interquartile range) overall adherence to RIC/sham was 91% (68%-100%). In patients with a stroke due to cerebral small vessel disease, who were adherent to treatment, RIC was associated with improved functional outcome, and the odds ratio for a shift to a lower score on the modified Rankin Scale was 2.54 (1.03-6.25);
    Conclusions: In patients with acute ischemic stroke due to cerebral small vessel disease, who maintained good treatment adherence, RIC was associated with improved functional outcomes at 90 days. These results should only serve as a hypothesis-generating for future trials.
    Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03481777.
    Mesh-Begriff(e) Adult ; Humans ; Female ; Adolescent ; Aged ; Aged, 80 and over ; Male ; Ischemic Stroke ; Ischemic Preconditioning/methods ; Activities of Daily Living ; Stroke/therapy ; Cerebral Small Vessel Diseases ; Treatment Outcome ; Randomized Controlled Trials as Topic
    Sprache Englisch
    Erscheinungsdatum 2024-02-01
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.123.046144
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: COVID-19 did not result in increased hospitalization for stroke and transient ischemic attack: A nationwide study.

    Simonsen, Claus Z / Blauenfeldt, Rolf A / Hedegaard, Jakob N / Kruuse, Christina / Gaist, David / Wienecke, Troels / Modrau, Boris / Johnsen, Søren P / Andersen, Grethe

    European journal of neurology

    2022  Band 29, Heft 8, Seite(n) 2269–2274

    Abstract: Background: The risk of thrombosis increases in infectious diseases, yet observational studies from single centers have shown a decrease in admission of acute ischemic stroke patients during the COVID-19 pandemic. To investigate unselected stroke ... ...

    Abstract Background: The risk of thrombosis increases in infectious diseases, yet observational studies from single centers have shown a decrease in admission of acute ischemic stroke patients during the COVID-19 pandemic. To investigate unselected stroke admission rates we performed a nationwide study in Denmark.
    Methods: We extracted information from Danish national health registries. The following mutually exclusive time periods were compared to the year before the lockdown: (1) first national lockdown, (2) gradual reopening, (3) few restrictions, (4) regional lockdown, and (5) second national lockdown.
    Results: Generally, admission rates were unchanged during the pandemic. In the unadjusted data, we observed a small decrease in the admission rate for all strokes under the first lockdown (incidence rate ratio: 0.93, confidence interval [CI]: 0.87-0.99) and a slight increase during the periods with gradual reopening, few restrictions, and the regional lockdown driven by ischemic strokes. We found no change in the rate of severe strokes, mild strokes, or 30-day mortality. An exception was the higher mortality for all strokes during the first lockdown (risk ratio: crude 1.30 [CI: 1.03-1.59]; adjusted 1.17 [CI: 0.93-1.47]). The quality of care remained unchanged.
    Conclusion: Stroke admission rates remained largely unchanged during the pandemic, while an increased short-term mortality rate in patients admitted with stroke observed during the first lockdown was seen, probably reflecting that the more frail patients constituted a higher proportion of admitted patients at the beginning of the pandemic.
    Mesh-Begriff(e) COVID-19/epidemiology ; Communicable Disease Control ; Hospitalization ; Humans ; Ischemic Attack, Transient/epidemiology ; Ischemic Attack, Transient/therapy ; Ischemic Stroke ; Pandemics ; Stroke/epidemiology ; Stroke/therapy
    Sprache Englisch
    Erscheinungsdatum 2022-04-21
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.15350
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Lasting impairments following transient ischemic attack and minor stroke: a systematic review protocol.

    Hede Ebbesen, Birgitte / Modrau, Boris / Kontou, Eirini / Finch, Emma / Crowfoot, Gary / Crow, Jennifer / Heron, Neil / Hodson, Tenelle / Skrubbeltrang, Conni / Turner, Grace

    Frontiers in neurology

    2023  Band 14, Seite(n) 1177309

    Abstract: Introduction: The focus on medical management and secondary prevention following Transient Ischemic Attack (TIA) and minor stroke is well-established. Evidence is emerging that people with TIA and minor stroke can experience lasting impairments as ... ...

    Abstract Introduction: The focus on medical management and secondary prevention following Transient Ischemic Attack (TIA) and minor stroke is well-established. Evidence is emerging that people with TIA and minor stroke can experience lasting impairments as fatigue, depression, anxiety, cognitive impairment, and communication difficulties. These impairments are often underrecognized and inconsistently treated. Research in this area is developing rapidly and an updated systematic review is required to evaluate new evidence as it emerges. This living systematic review aims to describe the prevalence of lasting impairments and how they affect the lives of people with TIA and minor stroke. Furthermore, we will explore whether there are differences in impairments experienced by people with TIA compared to minor stroke.
    Methods: Systematic searches of PubMed, EMBASE, CINAHL, PsycINFO, Cochrane Libraries will be undertaken. The protocol will follow the Cochrane living systematic review guideline with an update annually. A team of interdisciplinary reviewers will independently screen search results, identify relevant studies based on the defined criteria, conduct quality assessments, and extract data. This systematic review will include quantitative studies on people with TIA and/or minor stroke that report on outcomes in relation to fatigue, cognitive and communication impairments, depression, anxiety, quality of life, return to work/education, or social participation. Where possible, findings will be grouped for TIA and minor stroke and collated according to the time that follow-up occurred (short-term < 3 months, medium-term 3-12 months, and long-term > 12 months). Sub-group analysis on TIA and minor stroke will be performed based on results from the included studies. Data from individual studies will be pooled to perform meta-analysis where possible. Reporting will follow the Preferred Reporting Items for Systematic review and Meta-Analysis Protocol (PRISMA-P) guideline.
    Perspectives: This living systematic review will collate the latest knowledge on lasting impairments and how these affect the lives of people with TIA and minor stroke. It will seek to guide and support future research on impairments emphasizing distinctions between TIA and minor stroke. Finally, this evidence will allow healthcare professionals to improve follow-up care for people with TIA and minor stroke by supporting them to identify and address lasting impairments.
    Sprache Englisch
    Erscheinungsdatum 2023-05-12
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2023.1177309
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel: Machine Learning-Based Prediction of Brain Tissue Infarction in Patients With Acute Ischemic Stroke Treated With Theophylline as an Add-On to Thrombolytic Therapy: A Randomized Clinical Trial Subgroup Analysis.

    Modrau, Boris / Winder, Anthony / Hjort, Niels / Johansen, Martin Nygård / Andersen, Grethe / Fiehler, Jens / Vorum, Henrik / Forkert, Nils D

    Frontiers in neurology

    2021  Band 12, Seite(n) 613029

    Abstract: Background and Purpose: ...

    Abstract Background and Purpose:
    Sprache Englisch
    Erscheinungsdatum 2021-05-21
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2564214-5
    ISSN 1664-2295
    ISSN 1664-2295
    DOI 10.3389/fneur.2021.613029
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis.

    Modrau, Boris / Winder, Anthony / Hjort, Niels / Nygård Johansen, Martin / Andersen, Grethe / Fiehler, Jens / Vorum, Henrik / Forkert, Nils D

    Clinical neuroradiology

    2021  Band 32, Heft 2, Seite(n) 345–352

    Abstract: Purpose: Theophylline has been suggested to have a neuroprotective effect in ischemic stroke; however, results from animal stroke models and clinical trials in humans are controversial. The aim of this study was to assess the effect of theophylline on ... ...

    Abstract Purpose: Theophylline has been suggested to have a neuroprotective effect in ischemic stroke; however, results from animal stroke models and clinical trials in humans are controversial. The aim of this study was to assess the effect of theophylline on the cerebral perfusion with multiparametric magnetic resonance imaging (MRI).
    Methods: The relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative mean transit time (rMTT) in the infarct core, penumbra, and unaffected tissue were measured using multi-parametric MRI at baseline and 3‑h follow-up in patients treated with theophylline or placebo as an add-on to thrombolytic therapy.
    Results: No significant differences in mean rCBF, rCBV, and rMTT was found in the penumbra and unaffected tissue between the theophylline group and the control group between baseline and 3‑h follow-up. In the infarct core, mean rCBV increased on average by 0.05 in the theophylline group and decreased by 0.14 in the control group (p < 0.04). Mean rCBF and mean rMTT in the infarct core were similar between the two treatment groups.
    Conclusion: The results indicate that theophylline does not change the perfusion in potentially salvageable penumbral tissue but only affects the rCBV in the infarct core. In contrast to the penumbra, the infarct core is unlikely to be salvageable, which might explain why theophylline failed in clinical trials.
    Mesh-Begriff(e) Animals ; Brain Ischemia ; Cerebrovascular Circulation/physiology ; Humans ; Infarction/drug therapy ; Magnetic Resonance Imaging/methods ; Perfusion ; Stroke/diagnostic imaging ; Stroke/drug therapy ; Stroke/pathology ; Theophylline/therapeutic use ; Thrombolytic Therapy
    Chemische Substanzen Theophylline (C137DTR5RG)
    Sprache Englisch
    Erscheinungsdatum 2021-07-14
    Erscheinungsland Germany
    Dokumenttyp Journal Article ; Randomized Controlled Trial
    ZDB-ID 2234662-4
    ISSN 1869-1447 ; 0939-7116 ; 1869-1439
    ISSN (online) 1869-1447
    ISSN 0939-7116 ; 1869-1439
    DOI 10.1007/s00062-021-01029-x
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel: Acute Ischemic Stroke in Late Pregnancy Treated with Intravenous Thrombolysis and Endovascular Therapy.

    Szuchy Kristiansen, Eva / Holm Vestergaard, Hannah / Modrau, Boris / Oppel, Lorenz Martin

    Case reports in neurology

    2019  Band 11, Heft 1, Seite(n) 41–46

    Abstract: Pregnancy has usually been an exclusion criterion in clinical trials with thrombolysis and endovascular therapy in acute ischemic stroke. For that reason, these therapies are not recommended causing lack of evidence and vice versa. In this case report, ... ...

    Abstract Pregnancy has usually been an exclusion criterion in clinical trials with thrombolysis and endovascular therapy in acute ischemic stroke. For that reason, these therapies are not recommended causing lack of evidence and vice versa. In this case report, we describe a pregnant woman in week 33 + 3 presenting with acute ischemic stroke, which was successfully treated with systemic thrombolysis and endovascular therapy, resulting in a good clinical outcome for both mother and child. The altered fibrinolytic system and the risk factors related to pregnancy constitute a challenge for clinicians when choosing the most suitable treatment modality for treating acute ischemic stroke in pregnancy. It is still uncertain whether thrombolysis in combination with endovascular therapy or endovascular therapy alone is the most appropriate treatment option. However, there is slowly growing evidence that thrombolysis and thrombectomy in pregnancy are feasible and safe with a good clinical outcome for both the mother and the child.
    Sprache Englisch
    Erscheinungsdatum 2019-02-08
    Erscheinungsland Switzerland
    Dokumenttyp Case Reports
    ZDB-ID 2505302-4
    ISSN 1662-680X
    ISSN 1662-680X
    DOI 10.1159/000496084
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort study.

    Maksten, Eva Futtrup / Jakobsen, Lasse Hjort / Modrau, Boris / Jensvoll, Hilde / Kragholm, Kristian Hay / Jørgensen, Judit Mészáros / Clausen, Michael Roost / Pedersen, Robert Schou / Dessau-Arp, Andriette / Larsen, Thomas Stauffer / Poulsen, Christian Bjørn / Gang, Anne Ortved / Brown, Peter / El-Galaly, Tarec C / Severinsen, Marianne Tang

    Journal of geriatric oncology

    2023  Band 15, Heft 1, Seite(n) 101672

    Abstract: Introduction: Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a ... ...

    Abstract Introduction: Treatment of lymphoma can be associated with cognitive challenges, and some patients may fear development of dementia as long-term complication. Studies report a lower risk of dementia after cancer. Some believe this difference to be a protective mechanism of cancer, others believe it to be driven by bias. The risk of developing dementia after lymphoma has not been investigated in a population-based setting. The aim of this study was to identify the risk of being diagnosed with dementia after lymphoma treatment.
    Materials and methods: This Danish nationwide matched cohort study included patients aged ≥65 years with a first-time diagnosis of a non-central nervous system lymphoma between 2005 and 2018 in complete remission after treatment with chemotherapy. Patients diagnosed with dementia or treated with dementia medication before lymphoma diagnosis were excluded. Each patient was matched 1:5 on sex, year of birth, and a modified Charlson comorbidity index. Patients and matched comparators were followed from the corresponding patient's date of complete remission. The risk of developing dementia was calculated using cause-specific hazard ratios (HR), and the cumulative risk was estimated by Aalen-Johansen with death as the competing risk.
    Results: A total of 3,244 patients and 16,220 matched comparators were included in the study. There was no difference in risk of all-cause dementia among patients with lymphoma compared to matched comparators with cause-specific HR of 0.85 (95% confidence interval [CI]: 0.70;1.04). The risk of both Alzheimer's disease and non-Alzheimer's dementia was equal among patients and comparators: HR 0.89 (95% CI: 0.66;1.21) and 0.82 (95% CI: 0.63;1.07), respectively. Stratified by lymphoma subtype, age, or year of diagnosis, the risk of all-cause dementia remained equal among patients and matched comparators. The cumulative risk of all-cause dementia was significantly lower among patients with lymphoma compared to matched comparators (Gray's test p < 0.001), probably reflecting higher mortality in patients with lymphoma.
    Discussion: The risk of all-cause dementia, Alzheimer's disease, and non-Alzheimer's dementia was equal among older patients with lymphoma compared to matched comparators. Our data suggests that risk of developing dementia is not changed after lymphoma treatment.
    Mesh-Begriff(e) Humans ; Alzheimer Disease ; Cohort Studies ; Lymphoma/epidemiology ; Denmark/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2023-11-16
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2556813-9
    ISSN 1879-4076 ; 1879-4068
    ISSN (online) 1879-4076
    ISSN 1879-4068
    DOI 10.1016/j.jgo.2023.101672
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Transport Strategy in Patients With Suspected Acute Large Vessel Occlusion Stroke: TRIAGE-STROKE, a Randomized Clinical Trial.

    Behrndtz, Anne / Blauenfeldt, Rolf A / Johnsen, Søren P / Valentin, Jan B / Gude, Martin F / Al-Jazi, Mohammad Ahmad / von Weitzel-Mudersbach, Paul / Modrau, Boris / Damgaard, Dorte / Hougaard, Kristina Dupont / Hjort, Niels / Diedrichsen, Tove / Poulsen, Marika / Schmitz, Marie Louise / Fisher, Marc / Andersen, Grethe / Simonsen, Claus Z

    Stroke

    2023  Band 54, Heft 11, Seite(n) 2714–2723

    Abstract: Background: When patients with acute ischemic stroke present with suspected large vessel occlusion in the catchment area of a primary stroke center (PSC), the benefit of direct transport to a comprehensive stroke center (CSC) has been suggested. ... ...

    Abstract Background: When patients with acute ischemic stroke present with suspected large vessel occlusion in the catchment area of a primary stroke center (PSC), the benefit of direct transport to a comprehensive stroke center (CSC) has been suggested. Equipoise remains between transport strategies and the best transport strategy is not well established.
    Methods: We conducted a national investigator-driven, multicenter, randomized, assessor-blinded clinical trial. Patients eligible for intravenous thrombolysis (IVT) who were suspected for large vessel occlusion were randomized 1:1 to admission to the nearest PSC (prioritizing IVT) or direct CSC admission (prioritizing endovascular therapy). The primary outcome was functional improvement at day 90 for all patients with acute ischemic stroke, measured as shift towards a lower score on the modified Rankin Scale score.
    Results: From September 2018 to May 2022, we enrolled 171 patients of whom 104 had acute ischemic stroke. The trial was halted before full recruitment. Baseline characteristics were well balanced. Primary analysis of shift in modified Rankin Scale (ordinal logistic regression) revealed an odds ratio for functional improvement at day 90 of 1.42 (95% CI, 0.72-2.82,
    Conclusions: This trial investigated the benefit of bypassing PSC. We included only IVT-eligible patients presenting <4 hours from onset and with suspected large vessel occlusion. Lack of power prevented the results from showing effect on functional outcome for patients going directly to CSC.
    Registration: URL: https://www.
    Clinicaltrials: gov; Unique identifier: NCT03542188.
    Mesh-Begriff(e) Humans ; Brain Ischemia/drug therapy ; Brain Ischemia/etiology ; Ischemic Stroke/etiology ; Triage ; Endovascular Procedures/methods ; Stroke/diagnosis ; Stroke/drug therapy ; Thrombectomy/methods ; Treatment Outcome ; Thrombolytic Therapy/adverse effects
    Sprache Englisch
    Erscheinungsdatum 2023-10-06
    Erscheinungsland United States
    Dokumenttyp Randomized Controlled Trial ; Multicenter Study ; Journal Article
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.123.043875
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Quality in stroke care during the early phases of the COVID-19 pandemic: A nationwide study.

    Blauenfeldt, Rolf A / Hedegaard, Jakob N / Kruuse, Christina / Gaist, David / Wienecke, Troels / Modrau, Boris / Damgaard, Dorte / Johnsen, Søren P / Andersen, Grethe / Simonsen, Claus Z

    European stroke journal

    2022  Band 8, Heft 1, Seite(n) 268–274

    Abstract: Introduction: Evidence-based early stroke care as reflected by fulfillment of process performance measures, is strongly related to better patient outcomes after stroke and transient ischemic attack (TIA). Detailed data on the resilience of stroke care ... ...

    Abstract Introduction: Evidence-based early stroke care as reflected by fulfillment of process performance measures, is strongly related to better patient outcomes after stroke and transient ischemic attack (TIA). Detailed data on the resilience of stroke care services during the COVID-19 pandemic are limited. We aimed to examine the quality of early stroke care at Danish hospitals during the early phases of the COVID-19 pandemic.
    Materials and methods: We extracted data from Danish national health registries in five time periods (11 March, 2020-27 January, 2021) and compared these to a baseline pre-pandemic period (13 March, 2019-10 March, 2020). Quality of early stroke care was assessed as fulfilment of individual process performance measures and as a composite measure (opportunity-based score).
    Results: A total of 23,054 patients were admitted with stroke and 8153 with a TIA diagnosis in the entire period. On a national level, the opportunity-based score (95% confidence interval [CI]) at baseline for ischemic patients was 81.1% (80.8-81.4), for intracerebral hemorrhage (ICH) 85.5% (84.3-86.6), and for TIA 96.0% (95.3-96.1). An increase of 1.1% (0.1-2.2) and 1.5% (0.3-2.7) in the opportunity-based score was observed during the first national lockdown period for AIS and TIA followed by a decline of -1.3% (-2.2 to -0.4) in the gradual reopening phase for AIS indicators. We found a significant negative association between regional incidence rates and quality-of-care in ischemic stroke patients implying that quality decreases when admission rates increase.
    Conclusion: The quality of acute stroke/TIA care in Denmark remained high during the early phases of the pandemic and only minor fluctuations occurred.
    Mesh-Begriff(e) Humans ; Ischemic Attack, Transient/epidemiology ; Pandemics ; COVID-19/epidemiology ; Communicable Disease Control ; Stroke/epidemiology
    Sprache Englisch
    Erscheinungsdatum 2022-12-07
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2851287-X
    ISSN 2396-9881 ; 2396-9873
    ISSN (online) 2396-9881
    ISSN 2396-9873
    DOI 10.1177/23969873221139695
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: Acute Ischemic Stroke in Late Pregnancy Treated with Intravenous Thrombolysis and Endovascular Therapy

    Szuchy Kristiansen, Eva / Holm Vestergaard, Hannah / Modrau, Boris / Oppel, Lorenz Martin

    Case Reports in Neurology

    2019  Band 11, Heft 1, Seite(n) 41–46

    Abstract: Pregnancy has usually been an exclusion criterion in clinical trials with thrombolysis and endovascular therapy in acute ischemic stroke. For that reason, these therapies are not recommended causing lack of evidence and vice versa. In this case report, ... ...

    Körperschaft Faculty of Medicine, Aalborg University, Aalborg, Denmark
    Department of Neurology, University Hospital, Aalborg, Denmark
    Abstract Pregnancy has usually been an exclusion criterion in clinical trials with thrombolysis and endovascular therapy in acute ischemic stroke. For that reason, these therapies are not recommended causing lack of evidence and vice versa. In this case report, we describe a pregnant woman in week 33 + 3 presenting with acute ischemic stroke, which was successfully treated with systemic thrombolysis and endovascular therapy, resulting in a good clinical outcome for both mother and child. The altered fibrinolytic system and the risk factors related to pregnancy constitute a challenge for clinicians when choosing the most suitable treatment modality for treating acute ischemic stroke in pregnancy. It is still uncertain whether thrombolysis in combination with endovascular therapy or endovascular therapy alone is the most appropriate treatment option. However, there is slowly growing evidence that thrombolysis and thrombectomy in pregnancy are feasible and safe with a good clinical outcome for both the mother and the child.
    Schlagwörter Acute stroke ; Pregnancy ; Thrombolysis ; Endovascular therapy
    Sprache Englisch
    Erscheinungsdatum 2019-02-08
    Verlag S. Karger AG
    Erscheinungsort Basel, Switzerland
    Dokumenttyp Artikel
    Anmerkung Case Report ; This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC).
    ZDB-ID 2505302-4
    ISSN 1662-680X ; 1662-680X
    ISSN (online) 1662-680X
    ISSN 1662-680X
    DOI 10.1159/000496084
    Datenquelle Karger Verlag

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang